Development of bullous pemphigoid during secukinumab treatment for psoriasis
Journal
Journal of Dermatology
Journal Volume
44
Journal Issue
9
Pages
e220-e221
Date Issued
2017
Author(s)
Ho P.-H.
SDGs
Other Subjects
autoantibody; basement membrane antibody; BP180 antibody; clobetasol propionate; etretin; immunoglobulin; immunoglobulin C3; immunoglobulin G; methotrexate; secukinumab; topical agent; unclassified drug; ustekinumab; clobetasol; glucocorticoid; monoclonal antibody; secukinumab; adverse outcome; aged; antibody titer; blister; bullous pemphigoid; case report; clinical article; disease duration; drug efficacy; drug response; drug treatment failure; drug withdrawal; enzyme linked immunosorbent assay; eosinophilia; female; histopathology; human; immunofluorescence test; Letter; phototherapy; psoriasis; bullous pemphigoid; chemically induced; psoriasis; Aged; Antibodies, Monoclonal; Clobetasol; Enzyme-Linked Immunosorbent Assay; Female; Glucocorticoids; Humans; Pemphigoid, Bullous; Psoriasis
Publisher
Blackwell Publishing Ltd
Type
letter